Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/10715299

Download in:

View as

General Info

PMID
10715299